|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 281, Issue 46, 35413-35424, November 17, 2006
Interactions between TonB from Escherichia coli and the Periplasmic Protein FhuD* 1 2 3 4 5![]() ![]() ![]() 6 7
From the
For uptake of ferrichrome into bacterial cells, FhuA, a TonB-dependent outer membrane receptor of Escherichia coli, is required. The periplasmic protein FhuD binds and transfers ferrichrome to the cytoplasmic membrane-associated permease FhuB/C. We exploited phage display to map protein-protein interactions in the E. coli cell envelope that contribute to ferrichrome transport. By panning random phage libraries against TonB and against FhuD, we identified interaction surfaces on each of these two proteins. Their interactions were detected in vitro by dynamic light scattering and indicated a 1:1 TonB-FhuD complex. FhuD residue Thr-181, located within the siderophorebinding site and mapping to a predicted TonB-interaction surface, was mutated to cysteine. FhuD T181C was reacted with two thiol-specific fluorescent probes; addition of the siderophore ferricrocin quenched fluorescence emissions of these conjugates. Similarly, quenching of fluorescence from both probes confirmed binding of TonB and established an apparent KD of
Received for publication, August 9, 2006 * This work was supported in part by Operating Grant MOP-62774 (to J. W. C.) from the Canadian Institutes of Health Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 Recipient of the McGill Graduate Studies Fellowship and an F. C. Harrison Fellowship. 2 Recipient of a Natural Sciences and Engineering Research Council (Canada) Undergraduate Student Research Award. 3 Recipient of a postgraduate scholarship. 4 Trainee from theÉcole Supérieure de Biotechnologie, Strasbourg, France. Present address: Dept. of Life Science, Imperial College, London, UK. 5 Recipient of a traveling award for research training from the National Health and Medical Research Council (Australia). Present address: Dept. of Microbiology and Immunology, The University of Melbourne, Parkville, Australia. 6 Present address: Dept. of Chemistry and Biochemistry, Concordia University, Montreal, Quebec H4B 1R6, Canada. 7 To whom correspondence should be addressed: Dept. of Microbiology and Immunology, McGill University, 3775 University St., Montreal, Quebec H3A 2B4, Canada. Tel.: 514-398-3929; Fax: 514-398-7052; E-mail: james.coulton{at}mcgill.ca.
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||